Drug Trial Radar · NCT00559962
Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Last checked: Nov 20, 2026Latest source record: Feb 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
260
Actual
Start
Oct 2007
Primary completion
Oct 2008
Study completion Nov 2008
Sponsor
- Lead sponsor
- Aegerion Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine safety and effectiveness of low-dose therapeutic AEGR-733 +/- atorvastatin, ezetimibe or fenofibrate (compared to placebo) on liver fat accumulation measured by Magnetic Resonance Spectroscopy
Conditions
- Hyperlipidemia
Interventions
AEGR-733Drug
3 capsules each evening for each 4-week period
placeboDrug
3 capsules each evening for each 4-week period
AEGR-733Drug
3 capsules each evening for each 4-week period
AEGR-733Drug
3 capsules each evening for each 4-week period
AEGR-733Drug
3 capsules each evening for each 4-week period
AEGR-733 and atorvastatinDrug
3 capsules each evening for each 4-week period
AEGR-733 and fenofibrateDrug
3 capsules each evening for each 4-week period
AEGR-733 and ezetimibeDrug
3 capsules each evening for each 4-week period
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change From Baseline in Percent Hepatic FatTime frame: Baseline and 12 weeks on study drug
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Scripps Clinic
San Diego, California
Radiant Research
Santa Rosa, California
MedStar Research Institute
Washington D.C., District of Columbia
Radiant Research
Chicago, Illinois
University of Iowa
Iowa City, Iowa
LMARC
Louisville, Kentucky
Maine Research Associates
Auburn, Maine
Health Trends Research
Baltimore, Maryland
Johns Hopkins
Baltimore, Maryland
Washington Univ. School of Medicine
St Louis, Missouri
Sterling Research Group
Cincinnati, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
Baylor College of Medicine
Houston, Texas
Clinical Trial Network
Houston, Texas
dgd Research
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.